PCMA Preparing To Challenge Anti-PBM Lobbying At State Level
Executive Summary
The Pharmaceutical Care Management Association is beefing up its state-level lobbying to counteract anti-PBM activity by retail pharmacy groups
You may also be interested in...
NCPA Suggests AWP Reform Solution: “Pharmacy Payment Formula”
The National Community Pharmacists Association is developing a "Pharmacy Payment Formula" as a replacement for average wholesale price in determining reimbursement for prescription drugs
Pfizer, NCPA Agree Therapeutic Substitution Should Not Be Part Of Medicare
Pfizer and the National Community Pharmacists Association believe therapeutic substitution is not among the pharmacist care services that should be reimbursed under a Medicare prescription drug benefit.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011